4th Quarter - Report
NVG, LLC for ALEXION PHARMACEUTICALS
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
H.R. 9, Innovation Act; S. 1137, PATENT Act; General issues related to intellectual property and potential changes to the patent system
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Health Issues HCR
FDA - rare and orphan disease issues; H.R. 6, 21st Century CURES Act; Prescription drug coverage and payment policies; Medical innovation issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER | — |
| PATRICIA GRIFFIN New | — |
| ANDREA LARUE | — |
Trade (domestic/foreign) TRD
Trans Pacific Partnership Agreement
| Lobbyist | Covered position, as disclosed |
|---|---|
| LISA GERMAN FOSTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.